VH 032, propargyl

Background Introduction

VH 032, propargyl is a specially designed E3 ligase ligand-linker conjugate based on the widely used VH032 moiety, optimized for use in PROTAC (Proteolysis Targeting Chimera) technologies. The incorporation of a propargyl group enables convenient chemical conjugation with target-binding ligands, greatly enhancing versatility in targeted protein degradation research. As PROTAC-based therapeutics are rapidly advancing in drug discovery, VH 032, propargyl serves as a crucial tool for scientists developing next-generation targeted therapies.

Mechanism

VH 032, propargyl functions as an E3 ligase ligand-linker conjugate by leveraging its high-affinity binding to the von Hippel-Lindau (VHL) protein, a key component of the VHL E3 ubiquitin ligase complex. The propargyl functional group enables bioorthogonal conjugation (commonly through click chemistry) to a ligand for a protein of interest. When incorporated into bifunctional PROTAC molecules, the VH 032 moiety recruits the VHL E3 ligase to the target protein, facilitating its ubiquitination and subsequent degradation via the proteasome pathway. This mechanism enables specific and efficient elimination of disease-causing or pathogenic proteins within cells.

Applications

VH 032, propargyl finds broad application in the development of PROTAC molecules for research and drug discovery. It is highly suitable for scientists seeking to assemble custom PROTACs against a variety of target proteins in oncology, neurodegenerative diseases, and other therapeutic areas. Additionally, VH 032, propargyl is invaluable for studying protein homeostasis, validating novel drug targets, and generating chemical biology tool compounds. Its propargyl group makes it compatible with a range of conjugation chemistries, supporting modular design strategies in medicinal chemistry and chemical biology projects.

The E3 Ligase Ligand-Linker Conjugate, VH 032, propargyl, plays a pivotal role in the development of PROTACs by facilitating targeted protein degradation. This molecule is characterized by its efficient conjugation properties, enhancing selectivity and potency in degrading target proteins. The following provides a detailed description of this molecule, including its linker, ligand, and recommended target protein ligands.

Linker: The linker in VH 032, propargyl, is designed for optimal length and flexibility, allowing effective spatial orientation between the E3 ligase and the target protein. It is non-cleavable, ensuring stable conjugation and sustained activity in cellular environments.

Ligand: The ligand of this molecule is derived from the VH 032 series, known for its high affinity and specificity towards VHL (von Hippel-Lindau) E3 ligase. Structurally, it features a heterocyclic core that enhances its binding efficiency and stability.

Reactive Site: The reactive site of VH 032, propargyl, is a propargyl group that facilitates the coupling with the target protein ligand through click chemistry reactions, such as azide-alkyne cycloaddition, ensuring a robust and selective conjugation process.

Recommended Target Protein Ligand: The recommended warhead for this conjugate is an azide-functionalized ligand, which is compatible with the propargyl group for efficient click chemistry coupling. This combination offers high specificity and reduced off-target effects, making it suitable for diverse applications in studying protein function and validating therapeutic targets in vitro.